A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer
Titel:
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer
Auteur:
Natoli, C. Cianchetti, E. Tinari, N. Angelucci, D. Grassadonia, A. Zilli, M. Ficorella, C. Ricevuto, E. Grossi, S. De Tursi, M. Carella, C. Rispoli, A.I. Iacobelli, S.